PUBLICATIONS
Congratulations Dr. Kang
Link
December 14, 2023
Congratulations Dr. Minoli!
Link
July 11, 2023
Bladder cancer organoids as a functional system to model different disease stages and therapy response
Link
April 18, 2023
Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union
Link
May 12, 2023
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer
Link
April 1, 2022
Role of prostate and bone stromal cells on prostate cancer progression
Link
June 15, 2022
Bladder Cancer organoids as a functional system to model different disease stages and therapy response
Link
March 31, 2022
Translational Prostate Cancer Symposium 2022 - Lugano
Link
April 27, 2022
Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
Link
November 26, 2021
New post doc in the lab! Doctor La Manna

We are delighted to announce that PhD Candidate Federico La Manna successfully defended his doctoral dissertation on Friday, 14 October 2021 at the Universiteit Leiden. We would like to congratulate him warmly and wish him all the best for his future career!

Link
October 14, 2021
Over the next 4 years, we will be developing #singlecells #metabolomics approaches for #precision #medicine together with Prof. Theodore Alexandrov (EMBL) and Doctor Marianna Rapsomaniki (IBM Research)
Link
June 10, 2021
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
Link
May 7, 2021
New DBMR Board of Directors
Link
May 7, 2021
Predicting success in therapy with individualized cancer models
Link
March 8, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancer
Link
February 18, 2021
New biomarkers of aggressive prostate cancers will benefit those with more benign forms as well
Link
January 26, 2021
Merry Christmas from our Group
Link
December 19, 2020
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
Link
December 15, 2020
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
Link
August 10, 2020
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
Link
July 14, 2020
3RCC funds 3Rs projects worth CHF 1.3 million at Swiss universities
Link
July 6, 2020
2019 Call: Development of a platform for GU cancer patient-derived organoids
Link
June 26, 2020
A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
Link
June 8, 2020
Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Link
May 27, 2020
Genitourinary cancer treatment made personal
Link
May 19, 2020
Patient-derived xenografts and organoids model therapy response in prostate cancer
Link
April 7, 2020
Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Link
April 6, 2020

follow us on Twitter
dbmr.unibe.ch
urologie.insel.ch

created by fabiosodani
Urology Laboratory –DBMR 
Murtenstrasse 24
3008 Bern